Загрузка...
Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
There is a need for new combination regimens for tuberculosis. Identifying synergistic drug combinations can avoid toxic side effects and reduce treatment times. Using a fluorescent rifampicin conjugate, we demonstrated that synergy between cell wall inhibitors and rifampicin was associated with inc...
Сохранить в:
| Опубликовано в: : | Access Microbiol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Microbiology Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470358/ https://ncbi.nlm.nih.gov/pubmed/32974492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/acmi.0.000006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|